Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

B. Dahlof, R.B. Devereau, S.E. Kjeldsen, S. Julius, Dennis Johnston

Research output: Contribution to journalArticlepeer-review

4889 Citations (Scopus)
Original languageEnglish
Pages (from-to)995-1003
Number of pages9
JournalThe Lancet
Issue number9311
Publication statusPublished - 23 Mar 2002

ASJC Scopus subject areas

  • General Medicine

Cite this